Madrigal Pharmaceuticals (MDGL) PT Lowered to $542 at BofA Securities

June 11, 2026 5:11 AM

BofA Securities analyst Jason Zemansky lowered the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $542.00 (from $550.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found